BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30773180)

  • 1. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Rim CH; Kim HJ; Seong J
    Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review.
    Rim CH; Kim CY; Yang DS; Yoon WS
    Radiother Oncol; 2018 Oct; 129(1):112-122. PubMed ID: 29233562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
    Jang WI; Kim MS; Bae SH; Cho CK; Yoo HJ; Seo YS; Kang JK; Kim SY; Lee DH; Han CJ; Kim J; Park SC; Kim SB; Cho EH; Kim YH
    Radiat Oncol; 2013 Oct; 8():250. PubMed ID: 24160944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes.
    Shanker MD; Moodaley P; Soon W; Liu HY; Lee YY; Pryor DI
    J Med Imaging Radiat Oncol; 2021 Dec; 65(7):956-968. PubMed ID: 34396706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
    Bae SH; Chun SJ; Chung JH; Kim E; Kang JK; Jang WI; Moon JE; Roquette I; Mirabel X; Kimura T; Ueno M; Su TS; Tree AC; Guckenberger M; Lo SS; Scorsetti M; Slotman BJ; Kotecha R; Sahgal A; Louie AV; Kim MS
    Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):337-351. PubMed ID: 37597757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
    Jang WI; Bae SH; Kim MS; Han CJ; Park SC; Kim SB; Cho EH; Choi CW; Kim KS; Hwang S; Kim JH; Chang AR; Park Y; Kim ES; Kim WC; Jo S; Park HJ
    Cancer; 2020 Jan; 126(2):363-372. PubMed ID: 31747476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
    Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Yu T; Shin IS; Yoon WS; Rim CH
    Clin Lung Cancer; 2019 Jul; 20(4):e452-e462. PubMed ID: 31029573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L; Ke Q; Huang Q; Shao L; Chen J; Wu J
    Int J Hyperthermia; 2020; 37(1):1313-1321. PubMed ID: 33243024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
    Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
    Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
    J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S; Hardy-Abeloos C; Factor O; Rosenzweig K; Buckstein M
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2077-2083. PubMed ID: 30088143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review.
    Lee J; Yoon WS; Koom WS; Rim CH
    Strahlenther Onkol; 2019 Feb; 195(2):93-102. PubMed ID: 30206644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.
    Petrelli F; Comito T; Barni S; Pancera G; Scorsetti M; Ghidini A;
    Radiother Oncol; 2018 Dec; 129(3):427-434. PubMed ID: 29997034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.
    Lee J; Shin IS; Yoon WS; Koom WS; Rim CH
    Radiother Oncol; 2020 Apr; 145():63-70. PubMed ID: 31923711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.